Inventor · disambiguated record
Joseph L. Witztum
Also filed as: WITZTUM JOSEPH · WITZTUM JOSEPH L
32 granted patents·8 pending applications·421 citations·filing 1986–2023
97Inventor score
Files withUNIV CALIFORNIA21SCRIPPS RESEARCH INST5IONIS PHARMACEUTICALS INC4SCRIPPS CLINIC RES3INST NAT SANTE RECH MED2
Top patents by PatentIndex Score
40 records- 0194US12209119B2Method of treating rheumatoid arthritis using antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2023·Granted Jan 28, 2025·1 cites·19 claims
- 0294US11008381B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 18, 2021·7 cites·15 claims
- 0394US6716410B1Reagents and methods for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2000·Granted Apr 6, 2004·92 cites·19 claims
- 0493US11655288B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 23, 2023·5 cites·18 claims
- 0592US11008382B2Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2018·Granted May 18, 2021·5 cites·15 claims
- 0690US7939287B2Methods of identifying a subject having or at risk of having or developing coronary artery diseaseUNIV CALIFORNIA·Filed 2009·Granted May 10, 2011·15 cites·16 claims
- 0788US5408038ANonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptidesSCRIPPS RESEARCH INST·Filed 1992·Granted Apr 18, 1995·76 cites·12 claims
- 0886US11168148B2Antibodies to oxidation-specific epitopesUNIV CALIFORNIA·Filed 2017·Granted Nov 9, 2021·3 cites·18 claims
- 0984US9593333B2Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populationsIONIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 14, 2017·9 cites·23 claims
- 1079US11530259B2Therapies and methods to treat TLR2-mediated diseases and disordersUNIV CALIFORNIA·Filed 2019·Granted Dec 20, 2022·2 cites·14 claims
- 1179US7556927B2Methods for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2003·Granted Jul 7, 2009·5 cites·16 claims
- 1277US8361732B2Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2012·Granted Jan 29, 2013·2 cites·4 claims
- 1376US11897969B2Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injuryUNIV CALIFORNIA·Filed 2018·Granted Feb 13, 2024·1 cites·23 claims
- 1476US7575873B2Reagents for diagnosing, imaging and treating atherosclerotic diseaseUNIV CALIFORNIA·Filed 2003·Granted Aug 18, 2009·3 cites·8 claims
- 1574US12351649B2Antibodies to oxidation-specific epitopesUNIV CALIFORNIA·Filed 2021·Granted Jul 8, 2025·0 cites·13 claims
- 1674US9075050B2Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratiosUNIV CALIFORNIA·Filed 2013·Granted Jul 7, 2015·1 cites·5 claims
- 1773US8383355B2Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2009·Granted Feb 26, 2013·3 cites·15 claims
- 1870US6375925B1Methods and reagents for non-invasive imaging of atherosclerotic plaqueUNIV CALIFORNIA·Filed 1996·Granted Apr 23, 2002·44 cites·12 claims
- 1970US4828986AAssay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sampleSCRIPPS CLINIC RES·Filed 1986·Granted May 9, 1989·34 cites·13 claims
- 2069US5786206ADNA encoding recombinant lipoprotein antigensSCRIPPS RESEARCH INST·Filed 1994·Granted Jul 28, 1998·23 cites·12 claims
- 2169US2022213472A1Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populationsIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2269US2023357374A1Therapies and methods to treat tlr2-mediated diseases and disordersUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2368US9347959B2Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)UNIV CALIFORNIA·Filed 2013·Granted May 24, 2016·1 cites·16 claims
- 2467US8163504B2Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 2565US8129123B2Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratiosTSIMIKAS SOTIRIOS·Filed 2005·Granted Mar 6, 2012·2 cites·14 claims
- 2662US5330910AApolipoprotein B-specific monoclonal antibodies produced by two novel hybridomasSCRIPPS RESEARCH INST·Filed 1989·Granted Jul 19, 1994·12 cites·6 claims
- 2762US4778752AReceptors specific for hapten-modified self proteinsSCRIPPS CLINIC RES·Filed 1986·Granted Oct 18, 1988·21 cites·90 claims
- 2861US12441815B2Compositions and methods for diagnosis of cardiovascular diseaseUNIV CALIFORNIA·Filed 2019·Granted Oct 14, 2025·0 cites·16 claims
- 2961US8883428B2Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular riskWITZTUM JOSEPH L·Filed 2010·Granted Nov 11, 2014·1 cites·9 claims
- 3060US6225070B1Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheromaUNIV CALIFORNIA·Filed 1997·Granted May 1, 2001·26 cites·18 claims
- 3160US2015376268A1Antibodies to oxidized phospholipidsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3257US5460947AApolipoprotein B-specific monoclonal antibodies produced by two novel hybridomasSCRIPPS RESEARCH INST·Filed 1994·Granted Oct 24, 1995·12 cites·19 claims
- 3357US2020017854A1Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populationsIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3451US2017233732A1Modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populationsIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3550US2012149596A1Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein b ratiosTSIMIKAS SOTIRIOS·Filed 2012·Application pending·0 cites
- 3647US2007122419A1Methods and compositions for treating atherosclerosisUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 3746US4876188ANovel immunochemical method for assaying stable glycosylated hemoglobinSCRIPPS CLINIC RES·Filed 1986·Granted Oct 24, 1989·12 cites·14 claims
- 3846US2015056209A1Peptide mimotopes to oxidation specific epitopesUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 3927US9518088B2Peptide-phospholipid conjugatesVAN NIEUWENHZE MICHAEL S·Filed 2012·Granted Dec 13, 2016·0 cites·20 claims
- 4027US5169937AMethod for producing stable glycosylated hemoglobinSCRIPPS RESEARCH INST·Filed 1989·Granted Dec 8, 1992·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Joseph L. Witztum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →